JUPITER NEUROSCIENCES, INC. — SEC 8-K Filing
HealthcareFloridaAdd-on
Jupiter Neurosciences→PharmAla Biotech Holdings
May 20, 2026
Substance Abuse Treatment M&A Deals
15 dealsTrack substance abuse treatment acquisitions and investments within the healthcare sector.
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics - PR Newswire
HealthcareMerger
Neurocrine Biosciences→Soleno Therapeutics
May 18, 2026
Merck Completes $53-a-Share Acquisition of Terns Pharmaceuticals, Advancing Hematology Pipeline - citybiz
HealthcareMerger
Merck→Terns Pharmaceuticals
May 5, 2026
UCB Joins the Chase for Immune System Reset With $2B Acquisition
HealthcareMerger
UCB→Candid Therapeutics
May 4, 2026
UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers - Business Wire
HealthcareAdd-on
UCB→Candid Therapeutics
May 3, 2026
FLUENT Enters into Definitive Agreement to sell Texas Business
HealthcareTexasDivestiture
Legacy Therapeutics→Cansortium Texas
May 1, 2026
Vireo Growth To Acquire FLUENT In All-Stock Cannabis Transaction - Pulse 2.0
HealthcareFloridaPlatform
Vireo Growth→Fluent
May 1, 2026
Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio - Business Wire
HealthcarePlatform
Chiesi→KalVista Pharmaceuticals
Apr 29, 2026
UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
HealthcareAdd-on
UCB→Neurona Therapeutics
Apr 17, 2026
Eli Lilly Expands Into Sleep Medicine With Centessa Buyout - Centessa Pharmaceuticals (NASDAQ:CNTA), Eli - Benzinga
HealthcareMerger
Eli Lilly→Centessa Pharmaceuticals
Mar 31, 2026
Otsuka picks up PTSD drug with $700M Transcend buy
HealthcarePlatform
Otsuka→Transcend
Mar 27, 2026
Gilead Sciences to acquire Ouro Medicines, expanding autoimmune therapy portfolio - Proactive financial news
HealthcareOther
Gilead Sciences→Ouro Medicines
Mar 24, 2026
Chesterton addiction treatment center acquired by Alabama provider - Inside INdiana Business
HealthcareAlabama
Chesterton addiction treatment center
Feb 24, 2026
Cannabist Co Holdings Inc. — SEC 8-K Filing
HealthcareVirginiaDivestiture
Millstreet Credit Fund→Cannabist Company
Feb 6, 2026
Sobi Announces Acquisition of Arthrosi Therapeutics to Bolster Development of Novel Gout Therapies - The Healthcare Technology Report.
HealthcareCaliforniaAdd-on
Sobi→Arthrosi Therapeutics
Jan 5, 2026